Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration

Adjuvant chemoradiation (CRT), with high-dose cisplatin remains standard treatment for oral cavity squamous cell carcinoma (OCSCC) with high-risk pathologic features. We evaluated outcomes associated with different cisplatin dosing and schedules, concurrent with radiation (RT), and the effect of cum...

Descripción completa

Detalles Bibliográficos
Autores principales: Babar, Arslan, Woody, Neil M., Ghanem, Ahmed I., Tsai, Jillian, Dunlap, Neal E., Schymick, Matthew, Liu, Howard Y., Burkey, Brian B., Lamarre, Eric D., Ku, Jamie A., Scharpf, Joseph, Prendes, Brandon L., Joshi, Nikhil P., Caudell, Jimmy J., Siddiqui, Farzan, Porceddu, Sandro V., Lee, Nancy, Schwartzman, Larisa, Koyfman, Shlomo A., Adelstein, David J., Geiger, Jessica L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293216/
https://www.ncbi.nlm.nih.gov/pubmed/34209302
http://dx.doi.org/10.3390/curroncol28040221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293216/
https://www.ncbi.nlm.nih.gov/pubmed/34209302
http://dx.doi.org/10.3390/curroncol28040221

Ejemplares similares